Implied Podcast

Buy-now-pay-later giant Klarna just suffered a massive 22% crash down to $15.19—even after turning a net profit and beating second-quarter earnings expectations. The trigger? A full-year revenue guidance cut that sent Wall Street straight into panic mode. In this episode of Implied , we unpack why $600 million of that cut is just foreign exchange headwinds and German economic drag, while Klarna’s...

Liftoff Mobile just plunged nearly 10% in a single session, dragging the stock down toward its 52-week low. But here’s the paradox: the company actually crushed Q2 expectations, wiped out $409 million in debt, and saw major institutional insiders drop $60 million on shares with zero selling. So why is everyone running for the exits? In this episode of Implied, we break down why short-term tax nois...

Broadcom just took a sharp 6% plunge down toward $390—yet options traders instantly rushed in to buy over 230,000 call contracts. Why is big institutional money betting millions on a bounce while retail investors run for the exit? Despite tech debt fears triggering a market-wide selloff, Broadcom’s core AI engine is printing cash, pulling in $10.8 billion in custom AI chip revenue alone with mind-...

Cisco just crushed Wall Street expectations with record Q4 earnings, $9.3 billion in full-year AI orders, and raised long-term guidance—yet the stock plummeted nearly 9%. How does a tech giant post flawless numbers and still get hammered? In this episode of Implied , we break down how rising component costs and a minor gross margin squeeze triggered a classic "sell-the-news" reaction after a massi...

Life360 just suffered a brutal single-session collapse, plunging 24% despite posting a stellar 38% revenue jump and closing in on 100 million active users. So why did investors run for the exits? Wall Street had priced the software giant for pure perfection, and management’s decision to keep full-year guidance unchanged—coupled with a sudden exit from retail hardware sales—sparked a massive sellof...

AppLovin just suffered a dramatic single-day collapse, dropping nearly 20% from over $417 down to $330—despite pulling in $1.92 billion in revenue (up 53% year-over-year) and boasting a massive 84% profit margin. So why the sudden panic? A microscopic revenue miss against Wall Street's sky-high targets, combined with minor core gaming hiccups, was all it took for short-term traders to pull the tri...

Sterling Infrastructure (STRL) just blew past Q2 earnings estimates with a massive 90% revenue surge—yet the stock plunged 14% as investors panicked over creeping margin pressure. Why did a company powering the physical AI data center buildout get slammed despite raising its full-year EPS guidance to $20? In this episode of Implied , we break down the sharp divide between Sterling's booming $905 m...

TG Therapeutics just crashed 11%—despite posting a massive $240 million revenue blowout and raising its full-year guidance. Why the drop? Wall Street panicked when earnings missed targets after the company spent aggressively to scale manufacturing for a new subcutaneous version of its blockbuster MS drug, Briumvi. In this episode of Implied, we break down whether this selloff is just short-term no...

Alnylam Pharmaceuticals just suffered a brutal 26% single-day crash—despite posting a massive 74% revenue jump to $1.17 billion and turning a profit. Why did Wall Street panic? Because management lowered full-year guidance, signaling that early pent-up demand for its blockbuster drug, Amvuttra, is normalizing and the growth curve is flattening out. In this episode of Implied , we break down what h...

Vertiv Holdings just plunged 17% in a single session—despite reporting a massive 60% jump in adjusted earnings per share and raising its full-year revenue forecast to $14 billion. Why the sudden sell-off? Wall Street threw a fit over minor shipment timing delays that caused quarterly sales to slightly miss whisper estimates. But with Vertiv aggressively expanding its liquid-cooling manufacturing i...

Sanmina just suffered a brutal 18% crash in a single trading session—despite smashing quarterly earnings, expanding margins, and raising its full-year guidance. So why did Wall Street hit the panic button on this key AI hardware supplier? Between a broader tech selloff, growing AI capex jitters, and recent insider selling, pure market sentiment completely steamrolled fantastic operational numbers....

SanDisk has been one of the market's biggest AI winners, skyrocketing over 570% this year before suddenly plunging 11% in a single session. Despite blowing past Wall Street expectations with an unreal $23.41 EPS and joining the Nasdaq-100, a short seller report from Citron Research and broad tech profit-taking sparked instant market panic. Is this sudden selloff a classic "buy-the-dip" entry into...

Credo Technology Group (CRDO) just suffered a sharp 9% drop in a single trading session, leaving investors stunned despite posting a mind-boggling 157% year-over-year revenue explosion to $437 million. Why the sudden selloff? In this episode of Implied , we break down what triggered the sharp turn—from a $6.1 million insider share sale by the company's Chief Technology Officer to fast money profit...

Mobileye just plummeted 14% in a chaotic trading session following its latest quarterly update. Wall Street panicked over soft Q3 guidance and the sudden departure of founder and 27-year CEO Amnon Shashua—completely brushing aside a Q2 profit beat that was secretly fueled by a $93 million tax credit. Despite the executive shakeup and delivery delays from legacy automakers, Mobileye is sitting on $...

GE Vernova just tumbled over 8% following a Q2 profit miss—even as revenue surged 22% and orders blew past expectations. Wall Street punished the stock due to widening losses in the company’s troubled wind division, but under the hood, demand from AI data centers and grid upgrades is exploding with a massive $176 billion backlog. In this episode of Implied , we break down whether this selloff is a...

Danaher just delivered a textbook "beat-and-drop" mystery—plunging over 10% in a single session despite beating Q2 estimates and raising its full-year profit guidance. So why did investors panic? Management quietly trimmed its core revenue growth ceiling down to 3–4%, fueling fears over customer project delays in bioprocessing. Yet, underlying bioprocessing orders actually surged in the mid-teens....

Netflix just took a massive hit, plunging 7.26% after issuing a weak forward guidance outlook, missing quarterly revenue estimates, and announcing plans to pull back on quarterly subscriber metric disclosures. With insider stock sales topping $130 million and Wall Street trimming price targets, investors panicked over reduced metrics visibility and slowing growth. But is this sharp pullback just a...

Intuitive Surgical just shocked the market with a brutal 14% collapse , crashing straight to a fresh 52-week low. The twist? The robotic surgery giant actually beat Wall Street’s expectations on both the top and bottom lines, posting a massive $2.89 billion in revenue. So why the panic? In this episode, we break down the critical driver behind the selloff: management’s warning of a sudden decelera...

AST SpaceMobile just suffered a brutal one-day crash— plummeting over 17% —after a double-whammy of bad news caught Wall Street completely off guard. The company shocked investors by announcing a massive $1 billion private offering that triggered instant dilution panic, while simultaneously dropping a bombshell SEC filing: their commercial service launch is officially delayed until early 2027 . In...

Celcuity just scored its first-ever FDA approval for its blockbuster breast cancer drug, Revtorpyk—yet the stock immediately cratered by over 20%. Why did a massive medical milestone trigger an absolute bloodbath? Because Wall Street has zero patience for near-term launch hurdles, getting spooked by weekly clinic infusion logistics and a ticking cash-burn clock. In this episode of Implied , we bre...

IBM just shocked Wall Street with a massive 25% collapse—marking its worst single-day drop since 1968. The culprit? A surprise early Q2 earnings miss revealing that corporate clients are aggressively cannibalizing their enterprise software budgets to panic-buy AI hardware instead. In this episode of Implied , we break down the sudden market heart attack that sent shockwaves through peers like Micr...

AppLovin just suffered a massive 12.65% single-day crash, a shocking gut-punch for one of Wall Street's ultimate market darlings. After delivering a spectacular 14-fold return over the past three years, the stock plummeted as investors panicked over cooling growth signals and soft June data for its highly anticipated e-commerce ad rollout. Yet, with a jaw-dropping 84.5% adjusted EBITDA margin and...

Moderna investors just suffered massive whiplash. After hitting a fresh 52-week high, the stock plummeted 10.83% in a single day after JPMorgan caught the market off guard by naming it a top Q3 short idea. Despite securing a major new European vaccine contract, Wall Street is sounding the alarm over the company’s massive $3 billion R&D cash burn and a distinct lack of revenue guarantees. In th...

Ionis Pharmaceuticals just suffered a brutal gut-punch, with its stock plummeting nearly 19% after a highly anticipated Phase 3 heart drug trial completely missed its primary goals. The sudden failure wiped out all the momentum from a major FDA approval just weeks prior. But the real twist? Corporate insiders quietly dumped over $25 million in shares leading up to the announcement, leaving retail...

Masse Inc. just hit a wall, watching its stock plunge 15% in a single day as the hype behind its massive artificial intelligence pivot collided with cold, hard financial reality. The highly speculative tech name—which recently rebranded from a traditional Chinese wealth management firm to chase the AI infrastructure boom—reported a staggering 1.85 billion renminbi net loss alongside practically ne...